Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

50%

2 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
2(50.0%)
Early Phase 1
2(50.0%)
4Total
Phase 4(2)
Early Phase 1(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04703335Early Phase 1Unknown

Pilot Clinical Trial - Comparative Study of Two Material Concentration of OD-141309

Role: collaborator

NCT04942496Phase 4Unknown

A 96-hour Patch Test Study Using Healthy Human Volunteers to Assess the Skin Irritation Potential of 11 Topically Applied Formulations

Role: collaborator

NCT04654182Phase 4Completed

Evaluation of the Residual Antimicrobial Efficacy of One Test Material Based on a Modification of ASTM E1115-11 Test Method

Role: collaborator

NCT04495920Early Phase 1Completed

Clinical Evaluation of the Residual Antimicrobial Activity

Role: collaborator

All 4 trials loaded